Amneal Pharmaceuticals, Inc. company logo
Amneal Pharmaceuticals, Inc. logo

Amneal Pharmaceuticals, Inc. (AMRX) Cash From Operations

Annual CFO

$295.03M$111.87M+61.07%

Summary

Current Value
As of today, AMRX annual cash from operations is $295.03M, up +61.07% on
Historical Performance
AMRX annual cash from operations is up +22.00% over the past 3 years, and up +17203.70% over the past 5 years
All-Time High Comparison
AMRX annual cash from operations is currently -22.16% below its historical high of $379.00M set on
3-Year Low Comparison
AMRX annual cash from operations is +365.07% above its 3-year low of $63.44M reached on an earlier date
Sector Comparison
AMRX annual cash from operations is higher than 90.59% of companies in Healthcare sector

Cash From Operations Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AMRX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Operations$295.03M+61.1%+22.0%+10000.0%+3716.9%
Quarterly Cash From Operations$118.45M-16.4%+26.6%+164.5%+272.9%
TTM Cash From Operations$327.68M+117.0%+116.1%+47.5%+29.0%
Price$13.26+68.5%+500.0%+167.3%
Annual Cash From Investing-$63.00M+8.9%+67.6%-172.4%-189.1%
Annual Cash From Financing-$211.72M-322.1%-53.3%-400.6%-2700.2%
Annual Free Cash Flow$220.04M+93.1%+14.4%+329.9%+1074.7%
Annual CAPEX$74.99M+8.4%+51.7%-23.0%+420.1%
Annual Net Income-$73.88M-51.6%-466.3%+87.8%-247.8%

Cash From Operations Highs

AMRX Annual Cash From Operations Highs Comparison
PeriodHighDateCurrent
3Y$295.03Mat high
5Y$379.00MN/A-22.2%
All$379.00M-22.2%

Cash From Operations Lows

AMRX Annual Cash From Operations Lows Comparison
PeriodLowDateCurrent
3Y$63.44MN/A+365.1%
5Y$63.44M+365.1%
All-$19.22M+1634.8%

Cash From Operations History

YearValueChange
$295.03M+61.1%
$183.16M+188.7%
$63.44M-73.8%
$241.82M-36.2%
$379.00M>+9,900.0%
$1.71M-99.3%
YearValueChange
$250.23M+6.9%
$234.19M+213.9%
$74.60M+3.7%
$71.93M+119.2%
$32.82M-

FAQ

  • What is the current annual cash from operations of AMRX?

    As of today, AMRX annual cash from operations is $295.03M

  • What is 1-year change in AMRX annual cash from operations?

    AMRX annual cash from operations is up +61.07% year-over-year

  • What is 3-year change in AMRX annual cash from operations?

    AMRX annual cash from operations is up +22.00% over the past 3 years

  • How far is AMRX annual cash from operations from its all-time high?

    AMRX annual cash from operations is currently -22.16% below its historical high of $379.00M set on December 31, 2020

  • How does AMRX annual cash from operations rank versus sector peers?

    AMRX annual cash from operations is higher than 90.59% of companies in Healthcare sector

  • When is AMRX next annual earnings release?

    The next annual earnings release for AMRX is on

Cash From Operations Formula

CFO = + Non Cash Expenses + Changes In

Data Sources & References

  1. AMRX Official Website www.amneal.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1723128/000172312825000059/0001723128-25-000059-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1723128/000172312825000012/0001723128-25-000012-index.htm
  4. AMRX Profile on Yahoo Finance finance.yahoo.com/quote/AMRX
  5. AMRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amrx